Antibiotics List for Exam 1 CMOD Flashcards
CIPROFLOXACIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
Fluroquinolones
• MOA
o Bind and inhibit DNA gyrase (aka topoisomerase II) and topoisomerase IV.
o Inhibit DURING cutting step, preventing Reattachment
o DNA fragments accumulate leading to cell death
• Bacteria: E. COLI (resistance emerging), PSEUDOMONAS AERUGINOSA
• Bactericidal
Levofloxacin • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Fluroquinolones
• MOA
o Bind and inhibit DNA gyrase (aka topoisomerase II) and topoisomerase IV.
o Inhibit DURING cutting step, preventing Reattachment
o DNA fragments accumulate leading to cell death
• Bacteria: E.coli?, Pseudomonas aeruginosa?
• Bactericidal
RIFAMPIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Rifamycin
• MOA
o Bind PROKARYOTIC specific RNA polymerase
o Prevents initiation of RNA synthesis but not elongation
• Easily crosses lipophilic surfaces important for treatment of:
o Mycobacteria (mycolic acid walls) – MYCOBACTERIUM TB
o Staphlococcus Epidermidis and Aureus (Biofilm)
o Bacterial Meningitis (BBB penetration)
o Enters phagocytic cells
• Bactericidal
*Prevents INITIATION of RNA synthesis
Rifaximin • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Rifamycin
• MOA
o Bind PROKARYOTIC specific RNA polymerase
o Prevents initiation of RNA synthesis but not elongation
• Easily crosses lipophilic surfaces important for treatment of:
o Mycobacteria (mycolic acid walls)
o Staphlococcus Epidermidis and Aureus (Biofilm)
o Bacterial Meningitis (BBB penetration)
o Enters phagocytic cells
• Bactericidal
*Prevents INITIATION of RNA synthesis
METRONIDAZOLE • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Nitroimidazole
• MOA
o Pro-drug – must first be reduced by ferredoxin (a nitroreductase) which turns the nitroimidazole in to a toxic radical the FRAGMENTS DNA.
o Ferredoxin only used in ANAEROBIC bacteria
• Bacteria: Only effective against anaerobes
• Bactericidal
COTRIMOXAZOLE • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• DHFR Inhibitor/Sulfonamide combination drug of trimethroprim and sulfamethoxazole
• MOA
o Trimethroprim – inhibits PROKARYOTIC DHFR
o Sulfonamide - prevents step 1 of THF acid synthesis by preventing PABA and Pteridine reaction via Pteridine Synthetase
• Bacteria: E. COLI , Pneumocystis Jiroveci
• Bactericidal
Trimethoprim • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• DHFR inhibitor • MOA o Inhibition of PROKARYOTIC DHFR • Bacteria: ?? • Bactericidal
Sulfamethoxazole • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Sulfonamide • MOA o Inhibits step 1 of THF/DHF acid synthesis by preventing PABA and pteridine reaction via Pteridine Synthase inhibition • Bacteria: ?? • Bactericidal
DAPTOMYCIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Lipopeptide Antibiotic
• Bind to bacterial membranes and cause rapid depolarization of membrane potential ultimately DNA, RNA, and protein synthesis failed leading to cell death
o NOT effective in lungs due to Surfactant
• Bacteria: Gram (+) bacteria
• Bactericidal
FIDAXOMICIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
C. Diff Drug
• MOA
o inhibits RNA synthesis by inhibiting sigma dependent transcription
• Bacteria: pseudomembranous colitis (C. Diff)
Nitroflurantoin • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Broad-Spectrum • MOA o Get reduced by flavoproteins then alter ribosomes and other macromolecules • Bacteria: ?? • Bactericidal
***only reaches therapeutic concentrations IN URINE
GENTAMICIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
Aminoglycoside
• MOA
o Initial action: Deterioration of outer membrane
o Low Conc.: bind to 30S and cause misreading
o High Conc.: trap ribosome at AUG and prevent any translation
• Bacteria: gram (-) aerobes, Pseudomonas
• Bactericidal
Amikacin • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Aminoglycoside
• MOA
o Initial action: Deterioration of outer membrane
o Low Conc.: bind to 30S and cause misreading
o High Conc.: trap ribosome at AUG and prevent any translation
• Bacteria: gram (-) aerobes, Pseudomonas
• Bactericidal
Neomycin • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Aminoglycoside
• MOA
o Initial action: Deterioration of outer membrane
o Low Conc.: bind to 30S and cause misreading
o High Conc.: trap ribosome at AUG and prevent any translation
• Bacteria: gram (-) aerobes, Pseudomonas
• Bactericidal
Streptomycin • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Aminoglycoside
• MOA
o Initial action: Deterioration of outer membrane
o Low Conc.: bind to 30S and cause misreading
o High Conc.: trap ribosome at AUG and prevent any translation
• Bacteria: gram (-) aerobes, Pseudomonas
• Bactericidal
Tobramycin • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Aminoglycoside
• MOA
o Initial action: Deterioration of outer membrane
o Low Conc.: bind to 30S and cause misreading
o High Conc.: trap ribosome at AUG and prevent any translation
• Bacteria: gram (-) aerobes, Pseudomonas
• Bactericidal
AZITHROMYCIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Macrolides
• MOA
o Bind to 50S RSU (23S RNA part) and prevent AA transfer to new chain by blocking peptidyl Transferase
o Phagocytosed so may be carried by macrophages to infection site
• Bacteria: gram (-), gram (+)
• [low] = Bacteriostatic [high] = Bactericidal
CLARITHROMYCIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Macrolides
• MOA
o Bind to 50S RSU (23S RNA part) and prevent AA transfer to new chain by blocking peptidyl Transferase
o Phagocytosed so may be carried by macrophages to infection site
• Bacteria: gram (-), gram (+)
• [low] = Bacteriostatic [high] = Bactericidal
ERYTHROMYCIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Macrolides Least stable of macrolides, labile in stomach acid
• MOA
o Bind to 50S RSU (23S RNA part) and prevent AA transfer to new chain by blocking peptidyl Transferase
o Phagocytosed so may be carried by macrophages to infection site
• Bacteria: MYCOPLASMA PNEUMONIAE, gram (-), gram (+)
• [low] = Bacteriostatic [high] = Bactericidal
Quinpupristin/dalfopristin • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
Streptogramins
• MOA:
o 50S binding of both (near where macrolides bind) close binding leads to SYNERGISTIC effect
• Bacteria: ??
• Bactericidal - if synergistic binding of both occurs
CLINDAMYCIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
Lincosamides
• MOA:
o 50S RSU binding at 23S RNA part (PEPTIDYL TRANSFERASE) and cause premature dissociation of peptidyl -tRNA
• Bacteria: MRSA – when used in conjunction with vacomycin, gram (+), anaerobes
• Bacteriostatic
Useful in Toxin Producing Infections because it prevents toxin production and slows bacterial growth
LINEZOLID • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• MOA
o bind 50S ribosome at UNIQUE SITE protein synthesis inhibitor
o NO CROSS RESISTANCE
• Bacteria: MRSA
DOXYCYCLINE • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Tetracyclines
• MOA
o Bind 30S RSU (16S part) and inhibit protein synthesis by weaking ribosome-tRNA interaction
• Bacteria: gram (+), gram (-), some anaerobes
• Bacterstatic
*Mammals lack the ability to take it up so this helps with selectivity
TIGECYCLINE • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Tetracyclines
• MOA
o Bind 30S RSU (16S part) and inhibit protein synthesis by weaking ribosome-tRNA interaction
• Bacteria: gram (+), gram (-), some anaerobes
• Bacterstatic
*Mammals lack the ability to take it up so this helps with selectivity
Minocycline • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Tetracyclines
• MOA
o Bind 30S RSU (16S part) and inhibit protein synthesis by weaking ribosome-tRNA interaction
• Bacteria: gram (+), gram (+), some anaerobes
• Bacterstatic
*Mammals lack the ability to take it up so this helps with selectivity
Tetracycline • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
Tetracyclines
• MOA
o Bind 30S RSU (16S part) and inhibit protein synthesis by weaking ribosome-tRNA interaction
• Bacteria: gram (+), gram (+), some anaerobes
• Bacterstatic
*Mammals lack the ability to take it up so this helps with selectivity
MUPIROCIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Mupirocin
• MOA
o Isoleucyl transfer-RNA syntetase inhibition – NO CROSS-RESISTANCE with other classes
• Bacteria: gram (-) and gram (+) , Strep. Pyogenes and MRSA
• Bactricidal
Chlroamphenicol • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Mupirocin
• MOA
o Isoleucyl transfer-RNA syntetase inhibition – NO CROSS-RESISTANCE with other classes MAY INTERFERE WITH CLINDAMYCIN AND MACROLIDES
• Bacteria: gram (-) and gram (+) , Strep. Pyogenes and MRSA
• Bactricidal
FOSFOMYCIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Unknown group
• MOA
o Transported in via Glycerol3P or G6P transport system s
o Uses epoxide group to irreversibly inactivate enolpyruvyl transferase by taking place of phosphoenolpyruvate THIS HAPPENS EARLY IN CELL WALL SYNTH.
• Bacteria: ??
• Bactericidal
AMPICILLIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• AMINOPENICILLIN • MOA: o PBP binding inducing cell wall lysis o NH2 group allows it to cross lipid membrane of gram (-) bacteria • Bacteria: gram (+) and gram (-)
AZTREONAM • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
MONOBACTAM
• MOA
o PBP inhibitor – for one INSIDE the cell wall
o SULFONIC acid insteat of thiazole attached to ß-lactam ring
• Bacteria: gram (+)
• Bactricidal
PENICILLIN G • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Penicillin • MOA o Binds to PBP causing cell wall lysis • Bacteria: gram (+), STREPTOCOCCUS PNEUMONIAE, CLOSTRIDIUM PERFRINGENS • Bactericidal
PIPERACILLIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• AMINOPENICILLIN – BROAD SPECTRUM • MOA: o PBP binding inducing cell wall lysis o NH2 group allows it to cross lipid membrane of gram (-) bacteria • Bacteria: gram (+) and gram (-) • Bactericidal
IMIPENEM • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
Carbapenems
• MOA:
o Inhibit PBP
o Replacing sulfur with carbon in the thialzole ring makes it better at penetrating, gives it resistance to bacterial enzymes, and affinity for all PBPs
• Bacteria: gram(-) and gram (+) (PSEUDOMONAS AERUGINOSA)
• Bactericidal
IMIPENEM/CILASTIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Carbapenems
• MOA:
o Inhibit PBP
o 6 membered ring makes it better at penetrating, gives it resistance to bacterial enzymes, and affinity for all PBPs
• Bacteria: gram(-) and gram (+) (PSEUDOMONAS AERUGINOSA)
• Bactericidal
**CILASTIN inhibits DHP-2 in kidney proximal tubules INCREASING urinary concentration of Imipenem
AMOXICILLIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
AMINOPENICILLIN • MOA: o PBP binding inducing cell wall lysis o NH2 group allows it to cross lipid membrane of gram (-) bacteria • Bacteria: gram (+) and gram (-)
CALVULANIC ACID
Given with Piperacillin to inhibit ß-lactamases
TAZOBACTAM
Given with Piperacillin to inhibit ß-lactamases
Nafcillin • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Penicillin – NARROW spectrum
• MOA:
o PBP binding leading to cell wall degradation
o Bulky side chain inhibits ß-lactamases
• Bacteria: gram (+)
• Bactericidal
OXACILLIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal • Broad or Narrow Spectrum
• Penicillin – NARROW spectrum
• MOA:
o PBP binding leading to cell wall degradation
o Bulky side chain inhibits ß-lactamases
• Bacteria: gram (+), non-MRSA STAPH.
• Bactericidal
PENICILLIN V • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
Penicillin • MOA o Binds to PBP causing cell wall lysis • Bacteria: gram (+) • Bactericidal
VANCOMYCIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
Vancomycin
• MOA
o Prevents binding of traspeptidases to D-ala D-ala
• Bacteria: gram (+) (e.g. C. Diff), MRSA, (STREPTOCOCCUS PNEUMONIAE – only if resitance to penicillin)
• Bactericidal
Cefazolin • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal • WHEN is it used?
• Cephalosporin I
• MOA:
o 6 memebered ring, PBP inhibition leading to cell wall degradation
• Bacteria: Steptococcus or Staphylococcus
• Bactricidal
• SURGICAL PROPHYLAXIS
CEPHALEXIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal • WHEN is it used?
• Cephalosporin I
• MOA:
o 6 memebered ring, PBP inhibition leading to cell wall degradation
• Bacteria: Steptococcus or Staphylococcus
• Bactricidal
• OUT PATIENT USE
Cefepime • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal • Treats WHAT?
Cephalosporin IV
• MOA
o 6 memebered ring, PBP inhibition leading to cell wall degradation
• Bacteria: gram (-) anaerobes
• Treats – Pseudomonal Infections (PSEUDOMONAS AERUGINOSA)
CEFTRIAXONE • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal • Treats WHAT?
• Cephalosporin III
• MOA
o 6 memebered ring, PBP inhibition leading to cell wall degradation
• Bacteria: gram (-) anaerobes , STREPTOCOCCUS PNEUMONIAE
• Treats – pediatric meningitis